Compounds > azomycin
Page last updated: 2024-08-21

azomycin and Prostatic Neoplasms

azomycin has been researched along with Prostatic Neoplasms in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19903 (12.00)18.7374
1990's5 (20.00)18.2507
2000's7 (28.00)29.6817
2010's9 (36.00)24.3611
2020's1 (4.00)2.80

Authors

AuthorsStudies
Chapman, JD; Engelhardt, EL; Schneider, RF; Seeholzer, SH; Stobbe, CC1
Gaffney, J; Hompland, T; Leech, M; Leijenaar, RTH; Lyng, H; Marignol, L1
Ager, C; Ai, M; Balasubramanyam, S; Bartkowiak, T; Budhani, P; Curran, MA; Jaiswal, AR; Jayaprakash, P; Li, N; Liu, A; Nicholas, C; Ning, J; Shah, K; Sheng, J; Sun, Y; Wang, G; Zal, A; Zal, T1
Ahmed, M; Ba-Alawi, W; Beltran, H; Berlin, A; Boutros, PC; Bristow, RG; Chen, S; Ci, X; Ellis, L; Fazli, L; Feng, FY; Gleave, M; Guo, H; Haibe-Kains, B; He, HH; Hua, JT; Koritzinsky, M; Li, E; Liang, Y; Lin, D; Mahamud, O; Nguyen, T; Poirier, JT; Puca, L; Rudin, CM; Sheahan, AV; Soares, F; Su, P; Tsao, MS; van der Kwast, T; Vellanki, RN; Vosoughi, A; Wang, Y; Wouters, BG; Xu, J; Xu, X; Xue, H; Zhang, S; Zhang, Y; Zoubeidi, A1
Gulaka, PK; Kodibagkar, VD; Kovacs, Z; Mason, RP; Rojas-Quijano, F; Sherry, AD1
Saggar, JK; Tannock, IF1
Berndorff, D; Chang, E; Cheng, Z; Ellinghaus, P; Gambhir, SS; Gekeler, V; Liu, H; Liu, S; Unterschemmann, K1
Axcrona, K; Frikstad, KM; Hole, KH; Julin, CH; Lie, AK; Lyng, H; Ragnum, HB; Seierstad, T; Vlatkovic, L1
Ackerstaff, E; Carlin, S; Cho, H; Humm, JL; Koutcher, JA; Ling, CC; Lupu, ME; O'Donoghue, J; Rizwan, A; Wang, Y; Zanzonico, PB1
Chen, FH; Chiang, CS; Fu, SY; Hong, JH; Jung, SM; Lee, CC; Tsai, CS; Wang, CC; Wen, CJ1
Desmond, T; Garcia-Parra, R; Hussain, H; Meyer, C; Park, H; Piert, M; Shah, RB; Siddiqui, J; Wood, D1
Hagtvet, E; Olsen, DR; Røe, K1
Adomat, H; Bowden, M; Dragowska, W; Gleave, M; Koch, CJ; Skov, K; Woo, J; Yapp, DT1
Campa, J; Carlin, S; Humm, JL; Larson, SM; Ling, CC; Pugachev, A; Ruan, S1
Bentzen, SM; Carnell, DM; Daley, FM; Hoskin, PJ; Saunders, MI; Smith, RE1
Bentzen, SM; Carnell, DM; Collins, DJ; d'Arcy, JA; Daley, FM; Hoskin, PJ; Padhani, AP; Saunders, MI; Smith, RE; Stirling, JJ; Taylor, NJ1
Franko, AJ; Koch, CJ1
Chapman, JD; Mannan, RH; McEwan, AJ; McPhee, MS; Mercer, JR; Moore, RB; Wiebe, LI1
Biskupiak, JE; Krohn, KA1
Chapman, JD; Haynes, PT; Iyer, RV; Movsas, B; Schneider, RF1
Munzenrider, JE1
Buswell, L; Coleman, CN; Noll, L; Riese, N; Rose, MA1
Beckman, W; Gill, M; Joseph, AP; Kwock, L; McMurry, HL; Raleigh, JA1
Allen, PS; Franko, AJ; Kelly, DA; Raleigh, JA; Trimble, LA1
Brailovsky, CA; Corcos, J; Elhilali, MM; Fathi, MA; Fisher, GJ; Nigam, VN; Pageau, R; Tahan, TW1

Reviews

1 review(s) available for azomycin and Prostatic Neoplasms

ArticleYear
Recent advances in radiotherapy.
    Revista interamericana de radiologia, 1977, Volume: 2, Issue:3

    Topics: Breast Neoplasms; Bromodeoxyuridine; Carcinoid Tumor; Elementary Particles; Fast Neutrons; Hot Temperature; Humans; Male; Melanoma; Metronidazole; Neoplasms; Nitroimidazoles; Pancreatic Neoplasms; Prostatic Neoplasms; Protons; Radiation Protection; Radiation Tolerance; Radiation-Sensitizing Agents; Radioisotopes; Radiotherapy Dosage; Radiotherapy, High-Energy; Rectal Neoplasms; Salivary Gland Neoplasms; Sarcoma; Soft Tissue Neoplasms

1977

Trials

1 trial(s) available for azomycin and Prostatic Neoplasms

ArticleYear
The efficacy of pharmacokinetic monitoring and dose modification of etanidazole on the incidence of neurotoxicity: results from a phase II trial of etanidazole and radiation therapy in locally advanced prostate cancer.
    International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:3

    Topics: Adenocarcinoma; Combined Modality Therapy; Drug Evaluation; Etanidazole; Humans; Male; Nitroimidazoles; Peripheral Nervous System Diseases; Prostatic Neoplasms; Radiation-Sensitizing Agents

1992

Other Studies

23 other study(ies) available for azomycin and Prostatic Neoplasms

ArticleYear
The synthesis and radiolabeling of 2-nitroimidazole derivatives of cyclam and their preclinical evaluation as positive markers of tumor hypoxia.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Cell Hypoxia; Heterocyclic Compounds; Humans; Isotope Labeling; Male; Mice; Mice, SCID; Nitroimidazoles; Prostatic Neoplasms; Radionuclide Imaging; Rats; Rats, Inbred F344; Time Factors; Tissue Distribution; Tumor Cells, Cultured

2002
Exploring Hypoxia in Prostate Cancer With T2-weighted Magnetic Resonance Imaging Radiomics and Pimonidazole Scoring.
    Anticancer research, 2023, Volume: 43, Issue:1

    Topics: Humans; Magnetic Resonance Imaging; Male; Nitroimidazoles; Prostate; Prostatic Neoplasms; Retrospective Studies

2023
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy.
    The Journal of clinical investigation, 2018, 11-01, Volume: 128, Issue:11

    Topics: Adenocarcinoma; Animals; Cell Hypoxia; Cell Line, Tumor; Immunotherapy; Male; Mice; Mice, Knockout; Neoplasm Proteins; Neoplasms, Experimental; Nitroimidazoles; Phosphoramide Mustards; Prostatic Neoplasms; T-Lymphocytes

2018
ONECUT2 is a driver of neuroendocrine prostate cancer.
    Nature communications, 2019, 01-17, Volume: 10, Issue:1

    Topics: Animals; Carcinogenesis; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Datasets as Topic; Disease Progression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neuroendocrine Tumors; Nitroimidazoles; Phosphoramide Mustards; Prostate; Prostatic Neoplasms; RNA, Small Interfering; Signal Transduction; Smad3 Protein; Transcription Factors; Up-Regulation; Xenograft Model Antitumor Assays

2019
GdDO3NI, a nitroimidazole-based T1 MRI contrast agent for imaging tumor hypoxia in vivo.
    Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2014, Volume: 19, Issue:2

    Topics: Animals; Biological Transport; Cell Hypoxia; Contrast Media; Gadolinium; Magnetic Resonance Imaging; Male; Nitroimidazoles; Organometallic Compounds; Prostatic Neoplasms; Rats

2014
Activity of the hypoxia-activated pro-drug TH-302 in hypoxic and perivascular regions of solid tumors and its potential to enhance therapeutic effects of chemotherapy.
    International journal of cancer, 2014, Jun-01, Volume: 134, Issue:11

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cell Hypoxia; Docetaxel; Doxorubicin; Female; Humans; Male; Mice; Mice, Nude; Nitroimidazoles; Phosphoramide Mustards; Prodrugs; Prostatic Neoplasms; Taxoids; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2014
18F-FAZA PET imaging response tracks the reoxygenation of tumors in mice upon treatment with the mitochondrial complex I inhibitor BAY 87-2243.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Jan-15, Volume: 21, Issue:2

    Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Nude; Nitroimidazoles; Oxadiazoles; Positron-Emission Tomography; Prostatic Neoplasms; Pyrazoles; Radiopharmaceuticals; Tumor Burden; Xenograft Model Antitumor Assays

2015
The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer.
    British journal of cancer, 2015, Jan-20, Volume: 112, Issue:2

    Topics: Cell Hypoxia; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Nitroimidazoles; Proportional Hazards Models; Prostatic Neoplasms; Staining and Labeling; Tissue Distribution; Transcriptome

2015
Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia.
    Neoplasia (New York, N.Y.), 2009, Volume: 11, Issue:3

    Topics: Animals; Autoradiography; Cell Hypoxia; Disease Models, Animal; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Misonidazole; Nitroimidazoles; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rats

2009
Vasculatures in tumors growing from preirradiated tissues: formed by vasculogenesis and resistant to radiation and antiangiogenic therapy.
    International journal of radiation oncology, biology, physics, 2011, Aug-01, Volume: 80, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Bone Marrow Transplantation; Cell Aggregation; Cell Hypoxia; Cell Line, Tumor; Coloring Agents; Drug Resistance, Neoplasm; Endothelial Cells; Green Fluorescent Proteins; Indoles; Macrophages; Male; Mice; Mice, Inbred C57BL; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neovascularization, Pathologic; Nitroimidazoles; Prostatic Neoplasms; Pyrroles; Radiation Dosage; Radiation Tolerance; Radiation-Sensitizing Agents; Salvage Therapy; Sunitinib; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays

2011
Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques.
    European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:10

    Topics: Aged; Cell Hypoxia; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Nitroimidazoles; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed

2011
Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts.
    Radiation oncology (London, England), 2011, Oct-07, Volume: 6

    Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Combined Modality Therapy; Contrast Media; Doxorubicin; Humans; Hypoxia; Immunohistochemistry; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Theoretical; Neoplasm Transplantation; Nitroimidazoles; Prostatic Neoplasms; Treatment Outcome

2011
Hypoxia in the androgen-dependent Shionogi model for prostate cancer at three stages.
    Radiation research, 2004, Volume: 162, Issue:5

    Topics: Androgens; Animals; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Flow Cytometry; Hypoxia; Image Cytometry; Male; Mammary Neoplasms, Animal; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Nitroimidazoles; Prognosis; Prostatic Neoplasms; Protein Binding; Time Factors; Tumor Burden

2004
Dependence of FDG uptake on tumor microenvironment.
    International journal of radiation oncology, biology, physics, 2005, Jun-01, Volume: 62, Issue:2

    Topics: Animals; Autoradiography; Benzimidazoles; Bromodeoxyuridine; Cell Hypoxia; Cell Proliferation; Coloring Agents; Fluorodeoxyglucose F18; Glucose; Male; Mice; Mice, Nude; Neoplasms; Nitroimidazoles; Prostatic Neoplasms; Radiopharmaceuticals

2005
An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: implications for radioresistance.
    International journal of radiation oncology, biology, physics, 2006, May-01, Volume: 65, Issue:1

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Cell Hypoxia; Humans; Immunohistochemistry; Male; Middle Aged; Nitroimidazoles; Prostatic Neoplasms; Radiation-Sensitizing Agents

2006
Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations.
    International journal of radiation oncology, biology, physics, 2007, Jul-15, Volume: 68, Issue:4

    Topics: Aged; Cell Hypoxia; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nitroimidazoles; Oxygen; Prostatectomy; Prostatic Neoplasms; Radiation-Sensitizing Agents; Staining and Labeling

2007
Binding of misonidazole to V79 spheroids and fragments of Dunning rat prostatic and human colon carcinomas in vitro: diffusion of oxygen and reactive metabolites.
    International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:8

    Topics: Animals; Carbon Radioisotopes; Cells, Cultured; Colonic Neoplasms; Cricetinae; Cricetulus; Diffusion; Humans; In Vitro Techniques; Male; Misonidazole; Models, Biological; Nitroimidazoles; Oxygen; Prostatic Neoplasms; Rats; Tritium

1984
Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine-123-iodoazomycin arabinoside.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:3

    Topics: Animals; Brain; Cell Hypoxia; Iodine Radioisotopes; Magnetic Resonance Spectroscopy; Male; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Photochemotherapy; Prostatic Neoplasms; Radionuclide Imaging; Rats; Tumor Cells, Cultured

1993
Second generation hypoxia imaging agents.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:3

    Topics: Animals; Cell Hypoxia; Iodine Radioisotopes; Male; Nitroimidazoles; Oxygen; Photochemotherapy; Prostatic Neoplasms; Radionuclide Imaging; Rats

1993
Marking hypoxia in rat prostate carcinomas with beta-D-[125I]azomycin galactopyranoside and.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:2

    Topics: Anesthesia; Animals; Cell Hypoxia; Glucosides; Male; Microelectrodes; Neoplasm Transplantation; Nitroimidazoles; Organotechnetium Compounds; Oximes; Oxygen; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rats; Tumor Cells, Cultured

2001
Evaluation of a fluorinated 2-nitroimidazole binding to hypoxic cells in tumor-bearing rats by 19F magnetic resonance spectroscopy and immunohistochemistry.
    Radiation research, 1992, Volume: 129, Issue:1

    Topics: Adenocarcinoma; Animals; Cell Hypoxia; Evaluation Studies as Topic; Immunohistochemistry; Magnetic Resonance Spectroscopy; Male; Nitroimidazoles; Prostatic Neoplasms; Rats

1992
Development of an in vivo 19F magnetic resonance method for measuring oxygen deficiency in tumors.
    Magnetic resonance in medicine, 1991, Volume: 22, Issue:2

    Topics: Adenocarcinoma; Animals; Carcinoma 256, Walker; Cell Hypoxia; Female; Magnetic Resonance Spectroscopy; Male; Nitroimidazoles; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Tritium

1991
Combination of 60Co gamma-radiation, misonidazole, and maltose tetrapalmitate in the treatment of Dunning prostatic tumor in the rat.
    International journal of radiation oncology, biology, physics, 1985, Volume: 11, Issue:8

    Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cobalt Radioisotopes; Combined Modality Therapy; Glycolipids; Male; Misonidazole; Nitroimidazoles; Prostatic Neoplasms; Rats

1985